| La Roche-Posay | 91.7 | 3 | 4 |
| CNN.com | 60.0 | 4 | 0 |
| Aveeno | 58.2 | 2 | 1 |
| Cetaphil | 43.1 | 1 | 1 |
| CeraVe | 43.1 | 1 | 1 |
| Institut Esthederm | 43.1 | 1 | 1 |
| Dr. Jart+ | 43.1 | 1 | 1 |
| The Ordinary | 43.1 | 1 | 1 |
| Today | 41.0 | 2 | 0 |
| Vogue | 41.0 | 2 | 0 |
| Men's Health | 41.0 | 2 | 0 |
| Vichy | 41.0 | 2 | 0 |
| Neutrogena | 41.0 | 2 | 0 |
| Sara Sidner | 41.0 | 2 | 0 |
| Robb Report | 41.0 | 2 | 0 |
| Crossfire | 41.0 | 2 | 0 |
| Fareed Zakaria GPS | 41.0 | 2 | 0 |
| Reliable Sources | 41.0 | 2 | 0 |
| Weekend Today | 41.0 | 2 | 0 |
| The Sixties | 41.0 | 2 | 0 |
| CNNGo | 41.0 | 2 | 0 |
| United Shades of America | 41.0 | 2 | 0 |
| Forbes 30 Under 30 | 41.0 | 2 | 0 |
| Megyn Kelly Today | 41.0 | 2 | 0 |
| Chasing Life | 41.0 | 2 | 0 |
| Branwen R Drew | 41.0 | 2 | 0 |
| Forbes ASAP | 41.0 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 41.0 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 41.0 | 2 | 0 |
| Narad Bastola | 41.0 | 2 | 0 |
| cleanser | 34.5 | 0 | 3 |
| anti-aging cream | 34.5 | 0 | 3 |
| Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care | 34.5 | 0 | 3 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 34.5 | 0 | 3 |
| An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream | 34.5 | 0 | 3 |
| Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis | 34.5 | 0 | 3 |
| No7 product line | 27.3 | 0 | 2 |
| Perpendicular Strut Injection of Hyaluronic Acid Filler for Deep Wrinkles | 27.3 | 0 | 2 |
| A review of perineal skin care protocols and skin barrier product use | 27.3 | 0 | 2 |
| Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment | 27.3 | 0 | 2 |
| A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy | 27.3 | 0 | 2 |
| Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. | 27.3 | 0 | 2 |
| The effect of dietary and/or cosmetic argan oil on postmenopausal skin elasticity | 27.3 | 0 | 2 |
| Effect of standardized skin care regimens on neonatal skin barrier function in different body areas | 27.3 | 0 | 2 |
| Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care | 27.3 | 0 | 2 |
| Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis | 27.3 | 0 | 2 |
| Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage | 27.3 | 0 | 2 |
| Vitamin C restores healthy aging in a mouse model for Werner syndrome | 27.3 | 0 | 2 |
| Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation | 27.3 | 0 | 2 |
| Antiaging, photoprotective, and brightening activity in biorevitalization: a new solution for aging skin | 27.3 | 0 | 2 |
| Efficacy and tolerability of a facial serum for fine lines, wrinkles, and photodamaged skin | 27.3 | 0 | 2 |
| In vivo assessment of the effect of a cream containing Avena Rhealba® extract and hyaluronic acid on the restoration of the skin barrier in de-epidermised skin produced with an erbium-YAG laser | 27.3 | 0 | 2 |
| Chemical and Biochemical Aspects of the Glycosaminoglycans and Proteoglycans in Health and Disease | 27.3 | 0 | 2 |
| Improvement in skin wrinkles using a preparation containing human growth factors and hyaluronic acid serum | 27.3 | 0 | 2 |
| Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair | 27.3 | 0 | 2 |
| A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating an Oral Anti-aging Skin Care Supplement for Treating Photodamaged Skin | 27.3 | 0 | 2 |
| Perspectives in the selection of hyaluronic acid fillers for facial wrinkles and aging skin | 27.3 | 0 | 2 |
| Aging gracefully. Skin care for midlife and older women | 27.3 | 0 | 2 |
| Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management | 27.3 | 0 | 2 |
| Cohesive Polydensified Matrix Hyaluronic Acid for Fine Lines | 27.3 | 0 | 2 |
| Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea | 27.3 | 0 | 2 |
| Hyaluronic Acid Gel-Based Scaffolds as Potential Carrier for Growth Factors: An In Vitro Bioassay on Its Osteogenic Potential. | 27.3 | 0 | 2 |
| The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace | 27.3 | 0 | 2 |
| Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care | 27.3 | 0 | 2 |
| Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative | 27.3 | 0 | 2 |
| Exogenous Factors in Skin Barrier Repair | 27.3 | 0 | 2 |
| Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis | 27.3 | 0 | 2 |
| Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial | 27.3 | 0 | 2 |
| A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia. | 27.3 | 0 | 2 |
| Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients | 27.3 | 0 | 2 |
| Similar hormonal changes in sera from scorbutic and fasted (vitamin C-supplemented) guinea pigs, including decreased IGF-I and appearance of an IGF-I reversible mitogenic inhibitor. | 27.3 | 0 | 2 |
| Semipermeable glove membranes--effects on skin barrier repair following SLS irritation | 27.3 | 0 | 2 |
| Hyaluronic acid, B-glucuronidase, vitamin C and the immune defect in leprosy | 27.3 | 0 | 2 |
| Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? | 27.3 | 0 | 2 |
| Contact dermatitis from vitamin C in a cosmetic anti‐aging cream | 27.3 | 0 | 2 |
| P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption | 27.3 | 0 | 2 |
| Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid | 27.3 | 0 | 2 |
| Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase | 27.3 | 0 | 2 |
| Effect of semipermeable membranes on skin barrier repair following tape stripping | 27.3 | 0 | 2 |
| Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin. | 27.3 | 0 | 2 |
| Growth factors expression in hyaluronic acid fat graft myringoplasty | 27.3 | 0 | 2 |
| Response to letter to the editor re. Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace | 27.3 | 0 | 2 |
| Age transcended: a semiotic and rhetorical analysis of the discourse of agelessness in North American anti-aging skin care advertisements | 27.3 | 0 | 2 |
| Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment | 27.3 | 0 | 2 |
| Cerebrovascular and ventilatory responses to acute isocapnic hypoxia in healthy aging and lung disease: effect of vitamin C. | 27.3 | 0 | 2 |
| Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. | 27.3 | 0 | 2 |
| Regarding 'Frontal fibrosing alopecia: possible association with leave-on facial skincare products and sunscreens; a questionnaire study'. | 27.3 | 0 | 2 |
| Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils | 27.3 | 0 | 2 |
| Analysis of sensitive skin barrier function: basic indicators and sebum composition | 27.3 | 0 | 2 |
| Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis. | 27.3 | 0 | 2 |
| Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment | 27.3 | 0 | 2 |
| Clinical Evaluation of a Multi-Modal Facial Serum That Addresses Hyaluronic Acid Levels in Skin | 27.3 | 0 | 2 |
| Hyaluronic acid-based hydrogel scaffold without angiogenic growth factors enhances ovarian tissue function after autotransplantation in rats | 27.3 | 0 | 2 |
| Skin care and the topical treatment of aging skin | 27.3 | 0 | 2 |
| Examination of the skin barrier repair/wound healing process using a living skin equivalent (LSE) model and matrix-assisted laser desorption-ionization-mass spectrometry imaging (MALDI-MSI). | 27.3 | 0 | 2 |
| Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. | 27.3 | 0 | 2 |
| A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. | 27.3 | 0 | 2 |
| Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen | 27.3 | 0 | 2 |
| The Effect of a Combination of Recombinant EGF Cosmetic Serum and a Crosslinked Hyaluronic Acid Serum as Compared to a Fibroblast-Conditioned Media Serum on the Appearance of Aging Skin | 27.3 | 0 | 2 |
| Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. | 27.3 | 0 | 2 |
| Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation | 27.3 | 0 | 2 |
| Novel eye cream containing a mixture of human growth factors and cytokines for periorbital skin rejuvenation | 27.3 | 0 | 2 |
| Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. | 27.3 | 0 | 2 |
| Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. | 27.3 | 0 | 2 |
| Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy | 27.3 | 0 | 2 |
| Clinical, biophysical and immunohistochemical analysis of skin reactions to acute skin barrier disruption - a comparative trial between participants with sensitive skin and those with nonsensitive skin. | 27.3 | 0 | 2 |
| The Influence of Two Different Foam Creams on Skin Barrier Repair of Foot Xerosis: A Prospective, Double-Blind, Randomised, Placebo-Controlled Intra-Individual Study | 27.3 | 0 | 2 |
| Hyaluronic acid induces the release of growth factors from platelet-rich plasma | 27.3 | 0 | 2 |
| Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin | 27.3 | 0 | 2 |
| In response to Growth factors expression in hyaluronic acid fat graft myringoplasty | 27.3 | 0 | 2 |
| EFFECTS OF HIGH-DOSE VITAMIN C AND HYALURONIC ACID ON TENDON HEALING. | 27.3 | 0 | 2 |
| Production and characterization of hyaluronic acid microparticles for the controlled delivery of growth factors using a spray/dehydration method | 27.3 | 0 | 2 |
| Hyaluronic Acid, PRP/Growth Factors, and Stem Cells in the Treatment of Osteochondral Lesions | 27.3 | 0 | 2 |
| A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin | 27.3 | 0 | 2 |
| The Effect Of Hyaluronic Acid And Melatonin With Systemic Administration of Vitamin C On Implant Stability After Immediate Implant in Anterior Region | 27.3 | 0 | 2 |
| Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life | 27.3 | 0 | 2 |
| Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects | 27.3 | 0 | 2 |
| Tolerance and Efficacy Evaluation of 3 Face Creams | 27.3 | 0 | 2 |
| What is the Best Degree of Hyaluronic Acid Crosslinking in Increasing Growth Factors Level of Platelet-Rich Fibrin Lysate? | 27.3 | 0 | 2 |
| Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | 27.3 | 0 | 2 |
| Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | 27.3 | 0 | 2 |
| To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | 27.3 | 0 | 2 |
| Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions | 27.3 | 0 | 2 |
| Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test | 27.3 | 0 | 2 |
| Treatment of Knee Arthrosis With Platelet-derived Growth Factors vs. Hyaluronic Acid. | 27.3 | 0 | 2 |
| An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis | 27.3 | 0 | 2 |
| Cytokeratin expression and hyaluronic acid production in cultures of human synovial microvascular endothelial cells: influence of cytokines and growth factors | 27.3 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 27.3 | 0 | 2 |
| Dynamics of skin barrier repair following topical applications of miconazole nitrate | 27.3 | 0 | 2 |
| Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation | 27.3 | 0 | 2 |
| The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne | 27.3 | 0 | 2 |
| Dynamics of skin barrier repair following preconditioning by a biotechnology-driven extract from samphire (Crithmum maritimum) stem cells | 27.3 | 0 | 2 |
| Supplementation with Eskimo Skin Care improves skin elasticity in women. A pilot study | 27.3 | 0 | 2 |
| Pycnogenol® Effects on Skin Elasticity and Hydration Coincide with Increased Gene Expressions of Collagen Type I and Hyaluronic Acid Synthase in Women | 27.3 | 0 | 2 |
| Topical vitamin C in skin care | 27.3 | 0 | 2 |
| New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams | 27.3 | 0 | 2 |
| Effects of a three-session skin rejuvenation treatment using stabilized hyaluronic acid-based gel of non-animal origin on skin elasticity: a pilot study | 27.3 | 0 | 2 |
| Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid | 27.3 | 0 | 2 |
| Understanding skin care and skin barrier function in infants | 27.3 | 0 | 2 |
| Non‐invasive assessment of tryptophan fluorescence and confocal microscopy provide information on skin barrier repair dynamics beyond TEWL | 27.3 | 0 | 2 |
| An ex vivo human skin model for studying skin barrier repair | 27.3 | 0 | 2 |
| Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis | 27.3 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 27.3 | 0 | 2 |
| The effects of benzylsulfonyl-D-Ser-homoPhe-(4-amidino-benzylamide), a dual plasmin and urokinase inhibitor, on facial skin barrier function in subjects with sensitive skin | 27.3 | 0 | 2 |
| Comments to: Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace. J Eur Acad Dermatol Venereol. 2016, | 27.3 | 0 | 2 |
| [Anti-wrinkle creams with hyaluronic acid: how effective are they?] | 27.3 | 0 | 2 |
| In Reference to Growth factors expression in hyaluronic acid fat graft myringoplasty | 27.3 | 0 | 2 |
| Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study | 27.3 | 0 | 2 |
| Compromising human skin in vivo and ex vivo to study skin barrier repair | 27.3 | 0 | 2 |
| Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration | 27.3 | 0 | 2 |
| The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations | 27.3 | 0 | 2 |
| Intra-articular effects of combined xenogenous serum rich in growth factors (SRGF) and vitamin C on histopathology grading and staging of osteoarthritis in rat model | 27.3 | 0 | 2 |
| Relevant Topical Skin Care Products for Prevention and Treatment of Aging Skin | 27.3 | 0 | 2 |
| Amy Forman Taub | 27.3 | 0 | 2 |
| [Function of Sacran as an Artificial Skin Barrier and the Development of Skincare Products] | 27.3 | 0 | 2 |
| Determining the effectiveness of vitamin C in skin care by atomic force microscope | 27.3 | 0 | 2 |
| Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model | 27.3 | 0 | 2 |
| A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects | 27.3 | 0 | 2 |
| Exploratory study to evaluate two clinical methods for assessing moisturizing effect on skin barrier repair | 27.3 | 0 | 2 |
| Laboratory bioassay exploring the effects of anti-aging skincare products on free-living marine nematodes: a case study of collagen | 27.3 | 0 | 2 |
| Aging Skin: Skin Care and Differential Diagnoses for the Elder Mountaineer | 27.3 | 0 | 2 |
| Practical approaches to skin barrier recovery and maintenance: principles of cleansing for children and adults | 27.3 | 0 | 2 |
| Reducing Facial Wrinkle Size and Increasing Skin Firmness Using Skin Care Polymers | 27.3 | 0 | 2 |
| Safety and Efficacy of a Novel Antiaging Skin Care Regimen Containing Neutraceuticals and Growth Factors on the Facial Skin of Women: A 12-Week Open-label Study | 27.3 | 0 | 2 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | 27.3 | 0 | 2 |
| Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis | 27.3 | 0 | 2 |
| Challenges and Effective Routes for Formulating and Delivery of Epidermal Growth Factors in Skin Care | 27.3 | 0 | 2 |
| Evaluation of the Efficacy and Safety of Three Injectable Hyaluronic Acid-based Fillers: Art Filler® Fine Lines, Art Filler® Universal and Art Filler® Lips | 27.3 | 0 | 2 |
| A Clinical Trial Evaluating the Efficacy of a Skin Cream in Improving Facial Appearance and Skin Elasticity | 27.3 | 0 | 2 |
| anti-aging skin care kit product | 27.3 | 0 | 2 |
| Evaluating the gentleness of a new professional model sonic skin care brush though non-invasive measurements of the skin barrier | 27.3 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 27.3 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 27.3 | 0 | 2 |
| Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device | 27.3 | 0 | 2 |
| Interaction between the microbiota and the skin barrier in aging skin: a comprehensive review | 27.3 | 0 | 2 |
| 682 Induction of keratin 1 and keratin 10 expression by topical glucose in a mouse model of atopic dermatitis and in keratinocyte culture: A possible role of glucose in skin barrier repair | 27.3 | 0 | 2 |
| 674 TRPV1 positive peripheral sensory nerves are required for prompt skin barrier repair | 27.3 | 0 | 2 |
| Vitamin C compounds mixture prevents skin barrier alterations and inflammatory responses upon real life multi pollutant exposure | 27.3 | 0 | 2 |
| Akita | 27.3 | 0 | 2 |
| DabiDabi | 27.3 | 0 | 2 |
| Q137165079 | 27.3 | 0 | 2 |
| ALPLISH | 27.3 | 0 | 2 |
| SENSITIVE SKIN, LLC | 27.3 | 0 | 2 |
| PowerV | 27.3 | 0 | 2 |
| CNN | 25.8 | 1 | 0 |
| Jenna Bush Hager | 25.8 | 1 | 0 |
| Nordstrom | 25.8 | 1 | 0 |
| Financial Times | 25.8 | 1 | 0 |
| Bloomingdale's | 25.8 | 1 | 0 |
| Estée Lauder | 25.8 | 1 | 0 |
| Allure | 25.8 | 1 | 0 |
| La Roche-Posay | 25.8 | 1 | 0 |
| Glamour | 25.8 | 1 | 0 |
| Amorepacific Corporation | 25.8 | 1 | 0 |
| The World's Billionaires | 25.8 | 1 | 0 |
| Harper's Bazaar | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| The World's Most Powerful People | 25.8 | 1 | 0 |
| Connect the World | 25.8 | 1 | 0 |
| Forbes Global 2000 | 25.8 | 1 | 0 |
| Dateline NBC | 25.8 | 1 | 0 |
| Olay | 25.8 | 1 | 0 |
| Ethical Consumer | 25.8 | 1 | 0 |
| Mike Lazaridis | 25.8 | 1 | 0 |
| Larry King Live | 25.8 | 1 | 0 |
| Meet the Press | 25.8 | 1 | 0 |
| Korres | 25.8 | 1 | 0 |
| Lucire | 25.8 | 1 | 0 |
| L'Occitane en Provence | 25.8 | 1 | 0 |
| Simon Kuper | 25.8 | 1 | 0 |
| FT Magazine | 25.8 | 1 | 0 |
| Forbes 400 | 25.8 | 1 | 0 |
| Clinique Laboratories, LLC | 25.8 | 1 | 0 |
| American Morning | 25.8 | 1 | 0 |
| Asiaweek | 25.8 | 1 | 0 |
| NBC News | 25.8 | 1 | 0 |
| Candy Crowley | 25.8 | 1 | 0 |
| Martin Wolf | 25.8 | 1 | 0 |
| Kiehl's | 25.8 | 1 | 0 |
| Prevention | 25.8 | 1 | 0 |
| Lucy Kellaway | 25.8 | 1 | 0 |
| Kyra Phillips | 25.8 | 1 | 0 |
| CNN Freedom Project | 25.8 | 1 | 0 |
| CNN Airport Network | 25.8 | 1 | 0 |
| CNN Pipeline | 25.8 | 1 | 0 |
| Early Start | 25.8 | 1 | 0 |
| Hoda Kotb | 25.8 | 1 | 0 |
| Hooked: Muscle Women | 25.8 | 1 | 0 |
| British Vogue | 25.8 | 1 | 0 |
| Kiplinger | 25.8 | 1 | 0 |
| SK-II | 25.8 | 1 | 0 |
| SkinCeuticals | 25.8 | 1 | 0 |
| Ulta Beauty | 25.8 | 1 | 0 |
| Caudalie | 25.8 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 25.8 | 1 | 0 |
| Q11360653 | 25.8 | 1 | 0 |
| Tatler | 25.8 | 1 | 0 |
| CNN Newsroom | 25.8 | 1 | 0 |
| Anthony Bourdain: Parts Unknown | 25.8 | 1 | 0 |
| CNN Films | 25.8 | 1 | 0 |
| State of the Union | 25.8 | 1 | 0 |
| Mohamed Mansour | 25.8 | 1 | 0 |
| Medium | 25.8 | 1 | 0 |
| Feel Good Food | 25.8 | 1 | 0 |
| Who, What, Wear | 25.8 | 1 | 0 |
| The Colby Echo | 25.8 | 1 | 0 |
| Feel Good You | 25.8 | 1 | 0 |
| CNN Tonight | 25.8 | 1 | 0 |
| Dermalogica Inc. | 25.8 | 1 | 0 |
| Woman & Home | 25.8 | 1 | 0 |
| Physics arXiv Blog | 25.8 | 1 | 0 |
| Somebody's Gotta Do It | 25.8 | 1 | 0 |
| HuffPost | 25.8 | 1 | 0 |
| This is Life with Lisa Ling | 25.8 | 1 | 0 |
| The Seventies | 25.8 | 1 | 0 |
| Dermstore | 25.8 | 1 | 0 |
| Morgan Spurlock Inside Man | 25.8 | 1 | 0 |
| The Eighties | 25.8 | 1 | 0 |
| NBC Out | 25.8 | 1 | 0 |
| Rodan + Fields | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| vascular endothelial growth factor | 17.2 | 0 | 1 |
| vitamin | 17.2 | 0 | 1 |
| Tadeusz Reichstein | 17.2 | 0 | 1 |
| scurvy | 17.2 | 0 | 1 |
| Psidium guajava | 17.2 | 0 | 1 |
| Albert Szent-Györgyi | 17.2 | 0 | 1 |
| arteriosclerosis | 17.2 | 0 | 1 |
| Rita Levi-Montalcini | 17.2 | 0 | 1 |
| DL-ascorbic acid | 17.2 | 0 | 1 |
| vitamin C | 17.2 | 0 | 1 |
| Roger Y. Tsien | 17.2 | 0 | 1 |
| Norman Haworth | 17.2 | 0 | 1 |
| Stanley Cohen | 17.2 | 0 | 1 |
| Syzygium cumini | 17.2 | 0 | 1 |
| Clearasil | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| hyaluronic acid | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| growth factor | 17.2 | 0 | 1 |
| nerve growth factor | 17.2 | 0 | 1 |
| transforming growth factor | 17.2 | 0 | 1 |
| sodium ascorbate | 17.2 | 0 | 1 |
| life extension | 17.2 | 0 | 1 |
| toner | 17.2 | 0 | 1 |
| Edmund Hirst | 17.2 | 0 | 1 |
| personal lubricant | 17.2 | 0 | 1 |
| Donald Metcalf | 17.2 | 0 | 1 |
| skin care | 17.2 | 0 | 1 |
| cream | 17.2 | 0 | 1 |
| reticle | 17.2 | 0 | 1 |
| Revlon | 17.2 | 0 | 1 |
| hematopoietic growth factor | 17.2 | 0 | 1 |
| hyperalgesia | 17.2 | 0 | 1 |
| Biotherm | 17.2 | 0 | 1 |
| kangaroo care | 17.2 | 0 | 1 |
| Artistry | 17.2 | 0 | 1 |
| Edward Mellanby | 17.2 | 0 | 1 |
| dehydroascorbic acid | 17.2 | 0 | 1 |
| Hyaluronan sodium | 17.2 | 0 | 1 |
| ACE Drink | 17.2 | 0 | 1 |
| lenticula | 17.2 | 0 | 1 |
| NARS Cosmetics | 17.2 | 0 | 1 |
| Missha | 17.2 | 0 | 1 |
| Aesop | 17.2 | 0 | 1 |
| Alchimie Forever | 17.2 | 0 | 1 |
| Aquaphor | 17.2 | 0 | 1 |
| vascular stiffness | 17.2 | 0 | 1 |
| As Long as You're Loving Me | 17.2 | 0 | 1 |
| Bayankala | 17.2 | 0 | 1 |
| Bronner Bros. | 17.2 | 0 | 1 |
| Clarisonic | 17.2 | 0 | 1 |
| human skin | 17.2 | 0 | 1 |
| Ella Baché | 17.2 | 0 | 1 |
| EpiCeram | 17.2 | 0 | 1 |
| face cream | 17.2 | 0 | 1 |
| Esoterica | 17.2 | 0 | 1 |
| FGF15/19 | 17.2 | 0 | 1 |
| facial care | 17.2 | 0 | 1 |
| Freederm | 17.2 | 0 | 1 |
| Gold Bond | 17.2 | 0 | 1 |
| Graduation (Friends Forever) | 17.2 | 0 | 1 |
| Growth Factors Journal | 17.2 | 0 | 1 |
| sunspot | 17.2 | 0 | 1 |
| Redoxon | 17.2 | 0 | 1 |
| Me, Myself & I | 17.2 | 0 | 1 |
| More | 17.2 | 0 | 1 |
| Natural skin care | 17.2 | 0 | 1 |
| nucleobase cation symporter-2 | 17.2 | 0 | 1 |
| oncophage | 17.2 | 0 | 1 |
| Category:Vitamin C | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| Sensitive Skin Magazine | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin type | 17.2 | 0 | 1 |
| Category:Skin care | 17.2 | 0 | 1 |
| Simple Skincare | 17.2 | 0 | 1 |
| Skin cream | 17.2 | 0 | 1 |
| Smile | 17.2 | 0 | 1 |
| The Itch | 17.2 | 0 | 1 |
| neurotrophic receptor tyrosine kinase 2 | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| Vitamin C and the Common Cold | 17.2 | 0 | 1 |
| Vitamin C discography | 17.2 | 0 | 1 |
| Vitamin C and the common cold | 17.2 | 0 | 1 |
| Vitamin C megadosage | 17.2 | 0 | 1 |
| Category:Growth factors | 17.2 | 0 | 1 |
| Category:Songs written by Vitamin C (singer) | 17.2 | 0 | 1 |
| Category:Vitamin C (singer) albums | 17.2 | 0 | 1 |
| Category:Vitamin C (singer) songs | 17.2 | 0 | 1 |
| OXY | 17.2 | 0 | 1 |
| Vitamin C derivatives | 17.2 | 0 | 1 |
| Hada Labo | 17.2 | 0 | 1 |
| Cidesco | 17.2 | 0 | 1 |
| Template:Growth factors | 17.2 | 0 | 1 |
| viscosupplementation | 17.2 | 0 | 1 |
| Melem | 17.2 | 0 | 1 |
| cream | 17.2 | 0 | 1 |
| growth factor activity | 17.2 | 0 | 1 |
| cellular response to L-ascorbic acid | 17.2 | 0 | 1 |
| keratinocyte activation | 17.2 | 0 | 1 |
| NGF | 17.2 | 0 | 1 |
| TOR signaling | 17.2 | 0 | 1 |
| hyaluronic acid binding | 17.2 | 0 | 1 |
| glycosaminoglycan metabolic process | 17.2 | 0 | 1 |
| hyaluronan metabolic process | 17.2 | 0 | 1 |
| hyaluronan catabolic process | 17.2 | 0 | 1 |
| establishment of skin barrier | 17.2 | 0 | 1 |
| neurotrophin binding | 17.2 | 0 | 1 |
| neurotrophin receptor activity | 17.2 | 0 | 1 |
| Neurotrophic tyrosine kinase, receptor, type 2 | 17.2 | 0 | 1 |
| L-ascorbic acid metabolic process | 17.2 | 0 | 1 |
| dehydroascorbic acid transport | 17.2 | 0 | 1 |
| response to L-ascorbic acid | 17.2 | 0 | 1 |
| L-ascorbic acid binding | 17.2 | 0 | 1 |
| hyaluronan biosynthetic process | 17.2 | 0 | 1 |
| Pechoin | 17.2 | 0 | 1 |
| Face Cream | 17.2 | 0 | 1 |
| KORA Organics | 17.2 | 0 | 1 |
| angiocrine growth factors | 17.2 | 0 | 1 |
| Nardo's Natural | 17.2 | 0 | 1 |
| Rachel K | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| Q17478340 | 17.2 | 0 | 1 |
| Vitamin C can help prevent cancer say the National Institutes of Health | 17.2 | 0 | 1 |
| Johnson's Baby | 17.2 | 0 | 1 |
| Habp4 | 17.2 | 0 | 1 |
| Habp2 | 17.2 | 0 | 1 |
| Gm7770 | 17.2 | 0 | 1 |
| Gm3318 | 17.2 | 0 | 1 |
| ascorbic acid deficiency | 17.2 | 0 | 1 |
| Zoe Foster Blake | 17.2 | 0 | 1 |
| Template:Vitamin C | 17.2 | 0 | 1 |
| Skin care | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| L-ascorbic acid transmembrane transporter activity | 17.2 | 0 | 1 |
| Solute carrier family 23 member 1 | 17.2 | 0 | 1 |
| Hyaluronan binding protein 2 | 17.2 | 0 | 1 |
| epidermal lamellar body | 17.2 | 0 | 1 |
| neuregulin receptor activity | 17.2 | 0 | 1 |
| L-ascorbic acid biosynthetic process | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Solute carrier family 23 member 3 | 17.2 | 0 | 1 |
| Solute carrier family 23 member 2 | 17.2 | 0 | 1 |
| Stabilin 2 | 17.2 | 0 | 1 |
| Strategies to increase vitamin C in plants: from plant defense perspective to food biofortification | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor | 17.2 | 0 | 1 |
| Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells | 17.2 | 0 | 1 |
| Smoking, Green Tea Consumption, Genetic Polymorphisms in the Insulin-Like Growth Factors and Lung Cancer Risk | 17.2 | 0 | 1 |
| Recent loss of vitamin C biosynthesis ability in bats | 17.2 | 0 | 1 |
| Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| positive regulation of growth factor dependent skeletal muscle satellite cell proliferation | 17.2 | 0 | 1 |
| growth factor dependent regulation of skeletal muscle satellite cell proliferation | 17.2 | 0 | 1 |
| Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. | 17.2 | 0 | 1 |
| The roles of platelet-derived growth factors and their receptors in brain radiation necrosis | 17.2 | 0 | 1 |
| Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda | 17.2 | 0 | 1 |
| Vitamin C in human health and disease is still a mystery? An overview | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 2 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 4 | 17.2 | 0 | 1 |
| Synergistic and additive effects of hydrostatic pressure and growth factors on tissue formation | 17.2 | 0 | 1 |
| Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor (RHAMM) | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Solute carrier family 23 (nucleobase transporters), member 3 | 17.2 | 0 | 1 |
| Solute carrier family 23 (nucleobase transporters), member 2 | 17.2 | 0 | 1 |
| Solute carrier family 23 (nucleobase transporters), member 1 | 17.2 | 0 | 1 |
| Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function | 17.2 | 0 | 1 |
| The effects of angiogenic growth factors on extravillous trophoblast invasion and motility | 17.2 | 0 | 1 |
| Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2 | 17.2 | 0 | 1 |
| Human vitamin C (L-ascorbic acid) transporter SVCT1 | 17.2 | 0 | 1 |
| Vitamin C and Vitamin E for Alzheimer's Disease | 17.2 | 0 | 1 |
| The Possible Role of Antioxidant Vitamin C in Alzheimer’s Disease Treatment and Prevention | 17.2 | 0 | 1 |
| neuregulin binding | 17.2 | 0 | 1 |
| Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators | 17.2 | 0 | 1 |
| growth factor signaling initiating cell movement involved in cerebral cortex radial glia guided migration | 17.2 | 0 | 1 |
| L-ascorbic acid catabolic process | 17.2 | 0 | 1 |
| initiation of skeletal muscle satellite cell activation by growth factor signaling, involved in skeletal muscle regeneration | 17.2 | 0 | 1 |
| L-ascorbic acid transmembrane transport | 17.2 | 0 | 1 |
| neurotrophin production | 17.2 | 0 | 1 |
| regulation of L-ascorbic acid biosynthetic process | 17.2 | 0 | 1 |
| negative regulation of L-ascorbic acid biosynthetic process | 17.2 | 0 | 1 |
| negative regulation of growth factor dependent skeletal muscle satellite cell proliferation | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease EAE_08570 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease ECL_03999 | 17.2 | 0 | 1 |
| putative xanthine/uracil/vitamin C permease KPHS_36160 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Psyr_4286 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease L171588 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Moth_1232 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease LSEI_0151 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease NGR_b12650 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Smed_3842 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Smed_5276 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Smed_4615 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease L171588 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Moth_1232 | 17.2 | 0 | 1 |
| Putative xanthine/uracil/vitamin C permease family protein MAB_3353c | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Smed_3842 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Smed_5276 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Smed_4615 | 17.2 | 0 | 1 |
| Aveeno Baby product line | 17.2 | 0 | 1 |
| EOS Products, LLC | 17.2 | 0 | 1 |
| Combined effects of Matrigel and growth factors on maintaining undifferentiated murine embryonic stem cells for embryotoxicity testing | 17.2 | 0 | 1 |
| Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors | 17.2 | 0 | 1 |
| Hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential: selection of sperm for intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| Serum growth factors and oncoproteins in firefighters | 17.2 | 0 | 1 |
| The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid | 17.2 | 0 | 1 |
| Serum oncoproteins and growth factors in asbestosis and silicosis patients | 17.2 | 0 | 1 |
| Benzene and Its Principal Metabolites Modulate Proinflammatory Cytokines and Growth Factors in Human Epidermal Keratinocyte Cultures | 17.2 | 0 | 1 |
| Serum growth factors in asbestosis patients | 17.2 | 0 | 1 |
| Liposomal vitamin c | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Psyr_4286 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease NGR_b12650 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease EAE_08570 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease ECL_03999 | 17.2 | 0 | 1 |
| Arsenic induces overexpression of growth factors in human keratinocytes | 17.2 | 0 | 1 |
| Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. | 17.2 | 0 | 1 |
| Putative xanthine/uracil/vitamin C permease family protein MAB_3353c | 17.2 | 0 | 1 |
| Growth factors for treating diabetic foot ulcers | 17.2 | 0 | 1 |
| Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | 17.2 | 0 | 1 |
| Vitamin C for treating atrial fibrillation | 17.2 | 0 | 1 |
| Vitamin C supplementation in pregnancy | 17.2 | 0 | 1 |
| Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors | 17.2 | 0 | 1 |
| Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults | 17.2 | 0 | 1 |
| Growth factors for angiogenesis in peripheral arterial disease | 17.2 | 0 | 1 |
| Vitamin C supplementation for the primary prevention of cardiovascular disease | 17.2 | 0 | 1 |
| Vitamin C supplementation for asthma | 17.2 | 0 | 1 |
| Vitamin C and E for asthma and exercise-induced bronchoconstriction | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating pneumonia | 17.2 | 0 | 1 |
| Growth factors for chronic kidney disease in adults | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Vitamin C for asthma and exercise induced bronchoconstriction | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating tetanus | 17.2 | 0 | 1 |
| Vitamin C for asthma and exercise-induced bronchoconstriction | 17.2 | 0 | 1 |
| Growth factors for treating diabetic foot ulcers | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults | 17.2 | 0 | 1 |
| Vitamin C supplementation for asthma | 17.2 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 17.2 | 0 | 1 |
| Growth factors for chronic kidney disease in adults | 17.2 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating tetanus | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating pneumonia | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy | 17.2 | 0 | 1 |
| Haemopoietic growth factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating tetanus | 17.2 | 0 | 1 |
| Vitamin C supplementation in pregnancy | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating pneumonia | 17.2 | 0 | 1 |
| Vitamin C supplementation for asthma | 17.2 | 0 | 1 |
| Vitamin C supplementation in pregnancy | 17.2 | 0 | 1 |
| Putative xanthine/uracil/vitamin C permease KPHS_36160 | 17.2 | 0 | 1 |
| Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis | 17.2 | 0 | 1 |
| Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line | 17.2 | 0 | 1 |
| ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase | 17.2 | 0 | 1 |
| Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells | 17.2 | 0 | 1 |
| Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells | 17.2 | 0 | 1 |
| Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein | 17.2 | 0 | 1 |
| Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease | 17.2 | 0 | 1 |
| Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling | 17.2 | 0 | 1 |
| The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors | 17.2 | 0 | 1 |
| Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia | 17.2 | 0 | 1 |
| Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing | 17.2 | 0 | 1 |
| Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase | 17.2 | 0 | 1 |
| Opposite regulation of transforming growth factors-beta2 and -beta3 expression in the human endometrium | 17.2 | 0 | 1 |
| Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3 | 17.2 | 0 | 1 |
| Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation: a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope | 17.2 | 0 | 1 |
| Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors | 17.2 | 0 | 1 |
| Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors | 17.2 | 0 | 1 |
| Complete sequence of a human receptor for acidic and basic fibroblast growth factors | 17.2 | 0 | 1 |
| Transport model of the human Na+-coupled L-ascorbic acid (vitamin C) transporter SVCT1 | 17.2 | 0 | 1 |
| The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors | 17.2 | 0 | 1 |
| Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors | 17.2 | 0 | 1 |
| WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity | 17.2 | 0 | 1 |
| Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells | 17.2 | 0 | 1 |
| Diverse forms of a receptor for acidic and basic fibroblast growth factors | 17.2 | 0 | 1 |
| TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation | 17.2 | 0 | 1 |
| Functional role of conserved transmembrane segment 1 residues in human sodium-dependent vitamin C transporters | 17.2 | 0 | 1 |
| Hierarchal contribution of N- and C-terminal sequences to the differential localization of homologous sodium-dependent vitamin C transporters, SVCT1 and SVCT2, in epithelial cells | 17.2 | 0 | 1 |
| Expression and functions of the vascular endothelial growth factors and their receptors in human basophils | 17.2 | 0 | 1 |
| Stimulation of DNA synthesis in chicken muscle satellite cells by insulin and insulin-like growth factors: evidence for exclusive mediation by a type-I insulin-like growth factor receptor | 17.2 | 0 | 1 |
| E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein | 17.2 | 0 | 1 |
| Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2 | 17.2 | 0 | 1 |
| Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort | 17.2 | 0 | 1 |
| Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects | 17.2 | 0 | 1 |
| The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors | 17.2 | 0 | 1 |
| Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system | 17.2 | 0 | 1 |
| Functional interface between cathepsins and growth factors in the kidney development | 17.2 | 0 | 1 |
| Activity of a sodium-dependent vitamin C transporter (SVCT) in MDCK-MDR1 cells and mechanism of ascorbate uptake | 17.2 | 0 | 1 |
| Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells | 17.2 | 0 | 1 |
| Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors | 17.2 | 0 | 1 |
| Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2 | 17.2 | 0 | 1 |
| Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase | 17.2 | 0 | 1 |
| The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells | 17.2 | 0 | 1 |
| The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis | 17.2 | 0 | 1 |
| Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation | 17.2 | 0 | 1 |
| CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 | 17.2 | 0 | 1 |
| Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP) | 17.2 | 0 | 1 |
| Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway | 17.2 | 0 | 1 |
| RGD1565367 | 17.2 | 0 | 1 |
| Hyaluronic acid in human articular cartilage. Age-related changes in content and size | 17.2 | 0 | 1 |
| Growth factors induce differential phosphorylation profiles of the Hrs-STAM complex: a common node in signalling networks with signal-specific properties | 17.2 | 0 | 1 |
| The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3 | 17.2 | 0 | 1 |
| Hormonal changes throughout the menstrual cycle and increased anterior cruciate ligament laxity in females | 17.2 | 0 | 1 |
| Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity | 17.2 | 0 | 1 |
| The chemical nature of vitamin C | 17.2 | 0 | 1 |
| Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier | 17.2 | 0 | 1 |
| A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. | 17.2 | 0 | 1 |
| The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1 | 17.2 | 0 | 1 |
| Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid | 17.2 | 0 | 1 |
| High-dose vitamin C therapy: renewed hope or false promise? | 17.2 | 0 | 1 |
| Intravenously administered vitamin C as cancer therapy: three cases | 17.2 | 0 | 1 |
| HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. | 17.2 | 0 | 1 |
| Fibroblast growth factors | 17.2 | 0 | 1 |
| Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994 | 17.2 | 0 | 1 |
| A functional YY1 binding site is necessary and sufficient to activate Surf-1 promoter activity in response to serum growth factors | 17.2 | 0 | 1 |
| Growth factors can influence cell growth and survival through effects on glucose metabolism | 17.2 | 0 | 1 |
| The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors | 17.2 | 0 | 1 |
| Disruption of mouse SNM1 causes increased sensitivity to the DNA interstrand cross-linking agent mitomycin C | 17.2 | 0 | 1 |
| Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke | 17.2 | 0 | 1 |
| Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | 17.2 | 0 | 1 |
| Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection | 17.2 | 0 | 1 |
| A biomarker that identifies senescent human cells in culture and in aging skin in vivo | 17.2 | 0 | 1 |
| The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors | 17.2 | 0 | 1 |
| Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors | 17.2 | 0 | 1 |
| Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance | 17.2 | 0 | 1 |
| Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes | 17.2 | 0 | 1 |
| Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy | 17.2 | 0 | 1 |
| Identification of a cysteine-rich receptor for fibroblast growth factors | 17.2 | 0 | 1 |
| A human sodium-dependent vitamin C transporter 2 isoform acts as a dominant-negative inhibitor of ascorbic acid transport | 17.2 | 0 | 1 |
| Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors | 17.2 | 0 | 1 |
| Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis | 17.2 | 0 | 1 |
| Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors | 17.2 | 0 | 1 |
| Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates | 17.2 | 0 | 1 |
| Vitamin C Intake, Circulating Vitamin C and Risk of Stroke: A Meta‐Analysis of Prospective Studies | 17.2 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 17.2 | 0 | 1 |
| The genetics of vitamin C loss in vertebrates | 17.2 | 0 | 1 |
| Endocrine fibroblast growth factors 15/19 and 21: from feast to famine | 17.2 | 0 | 1 |
| Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel | 17.2 | 0 | 1 |
| A Critical Review of Vitamin C for the Prevention of Age-Related Cognitive Decline and Alzheimer's Disease | 17.2 | 0 | 1 |
| Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer | 17.2 | 0 | 1 |
| Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4 | 17.2 | 0 | 1 |
| Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins | 17.2 | 0 | 1 |
| One-year brain atrophy evident in healthy aging | 17.2 | 0 | 1 |
| Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1 | 17.2 | 0 | 1 |
| The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex | 17.2 | 0 | 1 |
| Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease | 17.2 | 0 | 1 |
| Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain | 17.2 | 0 | 1 |
| Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2 | 17.2 | 0 | 1 |
| Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2 | 17.2 | 0 | 1 |
| Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration | 17.2 | 0 | 1 |
| Vitamin C intake and the risk of gout in men: a prospective study | 17.2 | 0 | 1 |
| Vitamin C: update on physiology and pharmacology | 17.2 | 0 | 1 |
| Use of hyaluronic acid fillers for the treatment of the aging face | 17.2 | 0 | 1 |
| James Fries: healthy aging pioneer | 17.2 | 0 | 1 |
| Tropic Skin Care | 17.2 | 0 | 1 |
| Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis | 17.2 | 0 | 1 |
| Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer | 17.2 | 0 | 1 |
| Maturational loss of the vitamin C transporter in erythrocytes | 17.2 | 0 | 1 |
| Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies | 17.2 | 0 | 1 |
| Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D | 17.2 | 0 | 1 |
| Identification of hyaluronic acid binding sites in the extracellular domain of CD44 | 17.2 | 0 | 1 |
| Increased sensitivity to nitrazepam in old age | 17.2 | 0 | 1 |
| Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads | 17.2 | 0 | 1 |
| Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C | 17.2 | 0 | 1 |
| Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear | 17.2 | 0 | 1 |
| THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES | 17.2 | 0 | 1 |
| A FURTHER CONTRIBUTION TO VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS | 17.2 | 0 | 1 |
| VITAMIN C IN RELATION TO EXPERIMENTAL POLIOMYELITIS : WITH INCIDENTAL OBSERVATIONS ON CERTAIN MANIFESTATIONS IN MACACUS RHESUS MONKEYS ON A SCORBUTIC DIET | 17.2 | 0 | 1 |
| VITAMIN C THERAPY AND PROPHYLAXIS IN EXPERIMENTAL POLIOMYELITIS | 17.2 | 0 | 1 |
| INACTIVATION OF POLIOMYELITIS VIRUS IN VITRO BY CRYSTALLINE VITAMIN C (ASCORBIC ACID) | 17.2 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 17.2 | 0 | 1 |
| fibroblast growth factor family | 17.2 | 0 | 1 |
| Intracellular hyaluronic acid binding protein | 17.2 | 0 | 1 |
| Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system. | 17.2 | 0 | 1 |
| The enhancement of the hyperglycemic effect of S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine by vitamin C in an animal model | 17.2 | 0 | 1 |
| Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats | 17.2 | 0 | 1 |
| Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition | 17.2 | 0 | 1 |
| Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study | 17.2 | 0 | 1 |
| The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia | 17.2 | 0 | 1 |
| Growth factors in idiopathic pulmonary fibrosis: relative roles | 17.2 | 0 | 1 |
| Growth factors in lung development and disease: friends or foe? | 17.2 | 0 | 1 |
| Topically applied vitamin C increases the density of dermal papillae in aged human skin | 17.2 | 0 | 1 |
| Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function | 17.2 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 17.2 | 0 | 1 |
| The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemia | 17.2 | 0 | 1 |
| Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis | 17.2 | 0 | 1 |
| Mice with targeted disruption of p8 gene show increased sensitivity to lipopolysaccharide and DNA microarray analysis of livers reveals an aberrant gene expression response | 17.2 | 0 | 1 |
| Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors | 17.2 | 0 | 1 |
| Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis | 17.2 | 0 | 1 |
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | 17.2 | 0 | 1 |
| Hepatocyte and keratinocyte growth factors and their receptors in human lung emphysema | 17.2 | 0 | 1 |
| Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing | 17.2 | 0 | 1 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus | 17.2 | 0 | 1 |
| Misleading information on the properties of vitamin C | 17.2 | 0 | 1 |
| Narrow scope of vitamin C review | 17.2 | 0 | 1 |
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | 17.2 | 0 | 1 |
| Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data | 17.2 | 0 | 1 |
| Vitamin C inhibits benzo[a]pyrene-induced cell cycle changes partly via cyclin D1/E2F pathway in human embryo lung fibroblasts | 17.2 | 0 | 1 |
| Insulin-like growth factor receptor | 17.2 | 0 | 1 |
| Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling | 17.2 | 0 | 1 |
| Cleanser-induced effects on skin barrier function | 17.2 | 0 | 1 |
| Effect of dietary vitamin C on guinea pig pulmonary response to inhalation of cotton dust | 17.2 | 0 | 1 |
| Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors | 17.2 | 0 | 1 |
| Inhibition of cyclophosphamide and mitomycin c-induced sister chromatid exchanges in mice by vitamin c | 17.2 | 0 | 1 |
| Vitamin C for treating atrial fibrillation | 17.2 | 0 | 1 |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing | 17.2 | 0 | 1 |
| Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic Studies | 17.2 | 0 | 1 |
| Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms | 17.2 | 0 | 1 |
| Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis | 17.2 | 0 | 1 |
| Involvement of Fibroblast Growth Factors and Their Receptors in Epididymo-Testicular Descent and Maldescent | 17.2 | 0 | 1 |
| Insulin‐like growth factors and their potential role in cardiac epigenetics | 17.2 | 0 | 1 |
| Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies | 17.2 | 0 | 1 |
| Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance | 17.2 | 0 | 1 |
| Dietary restriction with and without caloric restriction for healthy aging | 17.2 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 17.2 | 0 | 1 |
| Hyaluronic acid and tendon lesions | 17.2 | 0 | 1 |
| Healthy aging: The ultimate preventative medicine | 17.2 | 0 | 1 |
| The Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy Aging | 17.2 | 0 | 1 |
| Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain | 17.2 | 0 | 1 |
| Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid | 17.2 | 0 | 1 |
| Dual action of vitamin C versus degradation and supplementation | 17.2 | 0 | 1 |
| 60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C | 17.2 | 0 | 1 |
| Radiofrequency for the treatment of skin laxity: mith or truth | 17.2 | 0 | 1 |
| Basic Research on Neurotrophic Factors and Its Application to Medical Uses | 17.2 | 0 | 1 |
| The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | 17.2 | 0 | 1 |
| Microspectroscopic Confocal Raman and Macroscopic Biophysical Measurements in the in vivo Assessment of the Skin Barrier: Perspective for Dermatology and Cosmetic Sciences | 17.2 | 0 | 1 |
| Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors | 17.2 | 0 | 1 |
| Overestimating the Effects of Healthy Aging | 17.2 | 0 | 1 |
| Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler | 17.2 | 0 | 1 |
| Putting age-related task activation into large-scale brain networks: A meta-analysis of 114 fMRI studies on healthy aging | 17.2 | 0 | 1 |
| MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression | 17.2 | 0 | 1 |
| Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis | 17.2 | 0 | 1 |
| The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis | 17.2 | 0 | 1 |
| Stem cells and growth factors in wound healing | 17.2 | 0 | 1 |
| Fibronectin Interaction and Enhancement of Growth Factors: Importance for Wound Healing | 17.2 | 0 | 1 |
| Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? | 17.2 | 0 | 1 |
| The Roles of Fibroblast Growth Factors in the Testicular Development and Tumor | 17.2 | 0 | 1 |
| Skin care: Historical and contemporary views | 17.2 | 0 | 1 |
| Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis | 17.2 | 0 | 1 |
| Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid | 17.2 | 0 | 1 |
| Healthy Aging: Is Smaller Better? – A Mini-Review | 17.2 | 0 | 1 |
| Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis | 17.2 | 0 | 1 |
| Growth factors, nutrient signaling, and cardiovascular aging | 17.2 | 0 | 1 |
| Vascular endothelial growth factors (VEGFs) and stroke | 17.2 | 0 | 1 |
| Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee | 17.2 | 0 | 1 |
| State-of-the-Art management of knee osteoarthritis | 17.2 | 0 | 1 |
| Coacervate delivery systems for proteins and small molecule drugs | 17.2 | 0 | 1 |
| Managing knee ostheoarthritis: efficacy of hyaluronic acid injections | 17.2 | 0 | 1 |
| Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders | 17.2 | 0 | 1 |
| Hyaluronic Acid and Wound Healing | 17.2 | 0 | 1 |
| Steering tumor progression through the transcriptional response to growth factors and stroma | 17.2 | 0 | 1 |
| Hematopoietic growth factors: personalization of risks and benefits | 17.2 | 0 | 1 |
| Hyaluronic acid hydrogels for vocal fold wound healing | 17.2 | 0 | 1 |
| Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials | 17.2 | 0 | 1 |
| The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review | 17.2 | 0 | 1 |
| Regulation of vitamin C homeostasis during deficiency | 17.2 | 0 | 1 |
| Vitamin C, Gastritis, and Gastric Disease: A Historical Review and Update | 17.2 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 17.2 | 0 | 1 |
| Insulin-Like Growth Factors in the Gastrointestinal Tract and Liver | 17.2 | 0 | 1 |
| Regulation of the Epigenome by Vitamin C | 17.2 | 0 | 1 |
| Growth Factors for the Treatment of Ischemic Brain Injury (Growth Factor Treatment) | 17.2 | 0 | 1 |
| Antioxidants in Athlete’s Basic Nutrition: Considerations towards a Guideline for the Intake of Vitamin C and Vitamin E | 17.2 | 0 | 1 |
| Characteristics of the Aging Skin | 17.2 | 0 | 1 |
| Multifaceted Role of Insulin-Like Growth Factors and Mammalian Target of Rapamycin in Skeletal Muscle | 17.2 | 0 | 1 |
| All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis | 17.2 | 0 | 1 |
| The Search for Longevity and Healthy Aging Genes: Insights From Epidemiological Studies and Samples of Long-Lived Individuals | 17.2 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 17.2 | 0 | 1 |
| Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis | 17.2 | 0 | 1 |
| Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair | 17.2 | 0 | 1 |
| Epidermal Permeability Barrier Defects and Barrier Repair Therapy in Atopic Dermatitis | 17.2 | 0 | 1 |
| Gene therapy with growth factors for periodontal tissue engineering-A review | 17.2 | 0 | 1 |
| Human Genetic Variation Influences Vitamin C Homeostasis by Altering Vitamin C Transport and Antioxidant Enzyme Function | 17.2 | 0 | 1 |
| Evaluation of Vitamin C for Adjuvant Sepsis Therapy | 17.2 | 0 | 1 |
| hyaluronan | 17.2 | 0 | 1 |
| beta-D-GlcpA-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpA-(1->3)-D-GlcpNAc | 17.2 | 0 | 1 |
| What drives the consistent use of long-lasting insecticidal nets over time? A multi-method qualitative study in mid-western Uganda | 17.2 | 0 | 1 |
| Increased sensitivity of the circadian system to temporal changes in the feeding regime of spontaneously hypertensive rats - a potential role for Bmal2 in the liver | 17.2 | 0 | 1 |
| The Effects of Hematopoietic Growth Factors on Neurite Outgrowth | 17.2 | 0 | 1 |
| Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens | 17.2 | 0 | 1 |
| Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation | 17.2 | 0 | 1 |
| Diminished vision in healthy aging is associated with increased retinal L-type voltage gated calcium channel ion influx | 17.2 | 0 | 1 |
| Image Statistics and the Fine Lines of Material Perception | 17.2 | 0 | 1 |
| Murine missing in metastasis (MIM) mediates cell polarity and regulates the motility response to growth factors | 17.2 | 0 | 1 |
| Selectivity in glycosaminoglycan binding dictates the distribution and diffusion of fibroblast growth factors in the pericellular matrix. | 17.2 | 0 | 1 |
| Intra-Myocardial Injection of Both Growth Factors and Heart Derived Sca-1+/CD31− Cells Attenuates Post-MI LV Remodeling More Than Does Cell Transplantation Alone: Neither Intervention Enhances Functionally Significant Cardiomyocyte Regeneration | 17.2 | 0 | 1 |
| Humidity trends imply increased sensitivity to clouds in a warming Arctic | 17.2 | 0 | 1 |
| Exposure to Sound Vibrations Lead to Transcriptomic, Proteomic and Hormonal Changes in Arabidopsis. | 17.2 | 0 | 1 |
| Increased Sensitivity of the Roche COBAS AMPLICOR HCV Test, Version 2.0, Using Modified Extraction Techniques | 17.2 | 0 | 1 |
| Structure of the enabled/VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly | 17.2 | 0 | 1 |
| The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity | 17.2 | 0 | 1 |
| Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition | 17.2 | 0 | 1 |
| The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site | 17.2 | 0 | 1 |
| Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution | 17.2 | 0 | 1 |
| Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase | 17.2 | 0 | 1 |
| A peptide derived from the C-terminal part of a plant cysteine protease folds into a stack of two beta-hairpins, a scaffold present in the emerging family of granulin-like growth factors | 17.2 | 0 | 1 |
| Solution structure of a Nedd4 WW domain-ENaC peptide complex | 17.2 | 0 | 1 |
| Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII | 17.2 | 0 | 1 |
| Hyaluronic acid: molecular conformations and interactions in two sodium salts | 17.2 | 0 | 1 |
| NMR trial models: experiences with the colicin immunity protein Im7 and the p85alpha C-terminal SH2-peptide complex | 17.2 | 0 | 1 |
| Hyaluronic acid: Structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms | 17.2 | 0 | 1 |
| Crystal structure of GRIP1 PDZ6-peptide complex reveals the structural basis for class II PDZ target recognition and PDZ domain-mediated multimerization | 17.2 | 0 | 1 |
| The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex | 17.2 | 0 | 1 |
| Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein | 17.2 | 0 | 1 |
| Solution structure and backbone dynamics of the AF-6 PDZ domain/Bcr peptide complex | 17.2 | 0 | 1 |
| Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex | 17.2 | 0 | 1 |
| The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops | 17.2 | 0 | 1 |
| Structural basis for Ca2+ -dependent formation of ALG-2/Alix peptide complex: Ca2+/EF3-driven arginine switch mechanism | 17.2 | 0 | 1 |
| Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity. | 17.2 | 0 | 1 |
| Crystal Structure of Fushi Tarazu Factor 1 Ligand Binding Domain/Fushi Tarazu Peptide Complex Identifies New Class of Nuclear Receptors | 17.2 | 0 | 1 |
| Contrast-Matched Small-Angle X-ray Scattering from a Heavy-Atom-Labeled Protein in Structure Determination: Application to a Lead-Substituted Calmodulin–Peptide Complex | 17.2 | 0 | 1 |
| Protein–peptide complex crystallization: a case study on the ERK2 mitogen-activated protein kinase | 17.2 | 0 | 1 |
| Structural and functional insights into lipid-bound nerve growth factors | 17.2 | 0 | 1 |
| Insulin-like growth factors in embryonic and fetal growth and skeletal development (Review) | 17.2 | 0 | 1 |
| Crystal structure of a phosphorylation-coupled vitamin C transporter | 17.2 | 0 | 1 |
| Healthy aging & clinical care in the elderly | 17.2 | 0 | 1 |
| Healthy aging research | 17.2 | 0 | 1 |
| Hyaluronic acid: The role of divalent cations in conformation and packing | 17.2 | 0 | 1 |
| Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen | 17.2 | 0 | 1 |
| Crystal Structure of an Anticholera Toxin Peptide Complex at 2·3 Å | 17.2 | 0 | 1 |
| Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove | 17.2 | 0 | 1 |
| NMR solution structure of an alpha-bungarotoxin/nicotinic receptor peptide complex | 17.2 | 0 | 1 |
| Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors | 17.2 | 0 | 1 |
| Solution structure of a naturally-occurring zinc-peptide complex demonstrates that the N-terminal zinc-binding module of the Lasp-1 LIM domain is an independent folding unit | 17.2 | 0 | 1 |
| Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis | 17.2 | 0 | 1 |
| Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody | 17.2 | 0 | 1 |
| The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide | 17.2 | 0 | 1 |
| Two Human T Cell Receptors Bind in a Similar Diagonal Mode to the HLA-A2/Tax Peptide Complex Using Different TCR Amino Acids | 17.2 | 0 | 1 |
| Structure of a Numb PTB domain-peptide complex suggests a basis for diverse binding specificity | 17.2 | 0 | 1 |
| The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors | 17.2 | 0 | 1 |
| Mode of receptor binding and activation by plasminogen‐related growth factors1 | 17.2 | 0 | 1 |
| Increased sensitivity of OSHA method analysis of diacetyl and 2,3-pentanedione in air | 17.2 | 0 | 1 |
| Perspectives on the Role and Synergies of Architecture and Social and Built Environment in Enabling Active Healthy Aging | 17.2 | 0 | 1 |
| Skin barrier in rosacea | 17.2 | 0 | 1 |
| Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration | 17.2 | 0 | 1 |
| Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature | 17.2 | 0 | 1 |
| Epithelial - Mesenchymal Interactions in Tooth Development and the Significant Role of Growth Factors and Genes with Emphasis on Mesenchyme - A Review | 17.2 | 0 | 1 |
| Knowledge brokering for healthy aging: a scoping review of potential approaches | 17.2 | 0 | 1 |
| Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review | 17.2 | 0 | 1 |
| Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors | 17.2 | 0 | 1 |
| Intravenous Vitamin C (PDQ®): Health Professional Version | 17.2 | 0 | 1 |
| The Neural Mechanisms of Meditative Practices: Novel Approaches for Healthy Aging | 17.2 | 0 | 1 |
| Developing food allergy: a potential immunologic pathway linking skin barrier to gut | 17.2 | 0 | 1 |
| Volumetric techniques: three-dimensional midface modeling | 17.2 | 0 | 1 |
| Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review | 17.2 | 0 | 1 |
| Biological Mechanisms Underlying the Ultraviolet Radiation-Induced Formation of Skin Wrinkling and Sagging I: Reduced Skin Elasticity, Highly Associated with Enhanced Dermal Elastase Activity, Triggers Wrinkling and Sagging | 17.2 | 0 | 1 |
| Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 | 17.2 | 0 | 1 |
| A healthy aging program for older adults: effects on self-efficacy and morale | 17.2 | 0 | 1 |
| Effectiveness of hyaluronic acid administration in treating adhesive capsulitis of the shoulder: a systematic review of randomized controlled trials | 17.2 | 0 | 1 |
| Functional diversity of fibroblast growth factors in bone formation | 17.2 | 0 | 1 |
| Targeting transporters: Promoting blood–brain barrier repair in response to oxidative stress injury | 17.2 | 0 | 1 |
| Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20 | 17.2 | 0 | 1 |
| ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production | 17.2 | 0 | 1 |
| CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration | 17.2 | 0 | 1 |
| Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors | 17.2 | 0 | 1 |
| Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans | 17.2 | 0 | 1 |
| Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant | 17.2 | 0 | 1 |
| Epithelin/granulin growth factors: extracellular cofactors for HIV-1 and HIV-2 Tat proteins | 17.2 | 0 | 1 |
| Angiogenic growth factors in human dentine matrix | 17.2 | 0 | 1 |
| Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice | 17.2 | 0 | 1 |
| Hormonal changes induced by partial rootzone drying of irrigated grapevine | 17.2 | 0 | 1 |
| Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins | 17.2 | 0 | 1 |
| Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells | 17.2 | 0 | 1 |
| Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation | 17.2 | 0 | 1 |
| Fibroblast growth factors, their receptors and signaling | 17.2 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice | 17.2 | 0 | 1 |
| Cosmetics and skin care products. A historical perspective | 17.2 | 0 | 1 |
| Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase | 17.2 | 0 | 1 |
| Does vitamin C act as a pro-oxidant under physiological conditions? | 17.2 | 0 | 1 |
| Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress | 17.2 | 0 | 1 |
| Phospholipid growth factors and corneal wound healing | 17.2 | 0 | 1 |
| Transcriptional regulation of Syndecan-1 expression by growth factors | 17.2 | 0 | 1 |
| Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells | 17.2 | 0 | 1 |
| Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke? | 17.2 | 0 | 1 |
| Gastroprotection by vitamin C--a heme oxygenase-1-dependent mechanism? | 17.2 | 0 | 1 |
| Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines | 17.2 | 0 | 1 |
| Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N‐terminal cell cycle regulator‐related domains | 17.2 | 0 | 1 |
| Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis | 17.2 | 0 | 1 |
| Factors associated with healthy aging: the cardiovascular health study | 17.2 | 0 | 1 |
| Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial | 17.2 | 0 | 1 |
| Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C | 17.2 | 0 | 1 |
| Acetylsalicylic acid and vitamin C | 17.2 | 0 | 1 |
| Fibroblast growth factors and their receptors in the central nervous system | 17.2 | 0 | 1 |
| Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors | 17.2 | 0 | 1 |
| Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry | 17.2 | 0 | 1 |
| Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species | 17.2 | 0 | 1 |
| Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2) | 17.2 | 0 | 1 |
| Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis | 17.2 | 0 | 1 |
| Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study | 17.2 | 0 | 1 |
| Immediate treatment of frostbite using rapid rewarming in tea decoction followed by combined therapy of pentoxifylline, aspirin & vitamin C | 17.2 | 0 | 1 |
| Low arterial saturation is associated with increased sensitivity to activated protein C in children with congenital heart disease | 17.2 | 0 | 1 |
| Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways | 17.2 | 0 | 1 |
| Vitamin C losses in some frozen vegetables due to various cooking methods | 17.2 | 0 | 1 |
| Vitamin C transport systems of mammalian cells | 17.2 | 0 | 1 |
| Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer | 17.2 | 0 | 1 |
| Skin care management: educational aspects | 17.2 | 0 | 1 |
| Emblica cascading antioxidant: a novel natural skin care ingredient | 17.2 | 0 | 1 |
| Role of vitamins in skin care | 17.2 | 0 | 1 |
| Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells | 17.2 | 0 | 1 |
| Regulation of the human vitamin C transporters expressed in COS-1 cells by protein kinase C [corrected] | 17.2 | 0 | 1 |
| Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs | 17.2 | 0 | 1 |
| Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma | 17.2 | 0 | 1 |
| Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy | 17.2 | 0 | 1 |
| Transferrin binds insulin‐like growth factors and affects binding properties of insulin‐like growth factor binding protein‐3 | 17.2 | 0 | 1 |
| The effect of cigarette smoking use and cessation on serum insulin-like growth factors | 17.2 | 0 | 1 |
| Growth factors improve latissimus dorsi muscle vascularization and trophicity after cardiomyoplasty | 17.2 | 0 | 1 |
| Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair | 17.2 | 0 | 1 |
| Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant | 17.2 | 0 | 1 |
| Induction of HSP27 nuclear immunoreactivity during stress is modulated by vitamin C | 17.2 | 0 | 1 |
| False-Negative Stool Occult Blood Tests Caused by Ingestion of Ascorbic Acid (Vitamin C) | 17.2 | 0 | 1 |
| Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts | 17.2 | 0 | 1 |
| Induction of cardiogenesis by Hensen's node and fibroblast growth factors | 17.2 | 0 | 1 |
| Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1 | 17.2 | 0 | 1 |
| The skin barrier as an innate immune element | 17.2 | 0 | 1 |
| Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update | 17.2 | 0 | 1 |
| Fibroblast growth factors induce additional limb development from the flank of chick embryos | 17.2 | 0 | 1 |
| Growth factors induce phosphorylation of the Na+/H+ antiporter, glycoprotein of 110 kD | 17.2 | 0 | 1 |
| Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins | 17.2 | 0 | 1 |
| Filaggrin in the frontline: role in skin barrier function and disease | 17.2 | 0 | 1 |
| Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP | 17.2 | 0 | 1 |
| Massive doses of vitamin C and the virus diseases | 17.2 | 0 | 1 |
| A novel method to inject hyaluronic acid: the Fern Pattern Technique | 17.2 | 0 | 1 |
| Functional rescue of vitamin C synthesis deficiency in human cells using adenoviral-based expression of murine l-gulono-gamma-lactone oxidase | 17.2 | 0 | 1 |
| Augmenter of liver regeneration: its place in the universe of hepatic growth factors | 17.2 | 0 | 1 |
| A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes | 17.2 | 0 | 1 |
| New developments and novel therapeutic perspectives for vitamin C | 17.2 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 17.2 | 0 | 1 |
| HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells | 17.2 | 0 | 1 |
| Elevated blood histamine caused by vaccinations and Vitamin C deficiency may mimic the shaken baby syndrome | 17.2 | 0 | 1 |
| Vascular endothelial growth factors VEGF-B and VEGF-C | 17.2 | 0 | 1 |
| In Vitro Bioaccessibility of Carotenoids, Flavonoids, and Vitamin C from Differently Processed Oranges and Orange Juices [Citrus sinensis (L.) Osbeck] | 17.2 | 0 | 1 |
| Sex steroids and growth factors in the regulation of mammary gland proliferation, differentiation, and involution | 17.2 | 0 | 1 |
| L-Gulono-1,4-lactone oxidase expression rescues vitamin C-deficient Arabidopsis (vtc) mutants | 17.2 | 0 | 1 |
| Evidence-based skin care management in radiation therapy | 17.2 | 0 | 1 |
| A C-terminal region dictates the apical plasma membrane targeting of the human sodium-dependent vitamin C transporter-1 in polarized epithelia | 17.2 | 0 | 1 |
| Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? | 17.2 | 0 | 1 |
| New approaches to coronary heart disease: induction of neovascularisation by growth factors | 17.2 | 0 | 1 |
| The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin | 17.2 | 0 | 1 |
| Intragenic deletion in the gene encoding L-gulonolactone oxidase causes vitamin C deficiency in pigs | 17.2 | 0 | 1 |
| The benefits of implementing a new skin care protocol in nursing homes | 17.2 | 0 | 1 |
| The validity of skin care protocols followed by women with breast cancer receiving external radiation | 17.2 | 0 | 1 |
| Vitamin C elevates red blood cell glutathione in healthy adults | 17.2 | 0 | 1 |
| Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? | 17.2 | 0 | 1 |
| The treatment of poliomyelitis and other virus diseases with vitamin C | 17.2 | 0 | 1 |
| Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome-associated Kaposi sarcoma tissue and derived cells | 17.2 | 0 | 1 |
| FURTHER OBSERVATIONS ON VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS | 17.2 | 0 | 1 |
| Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C | 17.2 | 0 | 1 |
| Hormonal changes when falling in love | 17.2 | 0 | 1 |
| Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency | 17.2 | 0 | 1 |
| Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm | 17.2 | 0 | 1 |
| Skin Care | 17.2 | 0 | 1 |
| Images in clinical medicine. Renal failure from vitamin C after transplantation | 17.2 | 0 | 1 |
| Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane | 17.2 | 0 | 1 |
| Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | 17.2 | 0 | 1 |
| Seasonal and climatic variation in cholesterol and vitamin C: effect of vitamin C supplementation | 17.2 | 0 | 1 |
| Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | 17.2 | 0 | 1 |
| Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options | 17.2 | 0 | 1 |
| In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen | 17.2 | 0 | 1 |
| Exploring the relationship between personality and regional brain volume in healthy aging | 17.2 | 0 | 1 |
| Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis | 17.2 | 0 | 1 |
| Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia | 17.2 | 0 | 1 |
| Fibroblast growth factors as tissue repair and regeneration therapeutics | 17.2 | 0 | 1 |
| Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C | 17.2 | 0 | 1 |
| Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases oxidative stress in healthy humans: a comparative study with vitamin C | 17.2 | 0 | 1 |
| Vitamin C-aspirin interactions | 17.2 | 0 | 1 |
| Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma | 17.2 | 0 | 1 |
| An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of moderate to severe xerosis, epidermolytic hyperkeratosis, and ichthyosis | 17.2 | 0 | 1 |
| Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study | 17.2 | 0 | 1 |
| The Infant Skin Barrier: Can We Preserve, Protect, and Enhance the Barrier? | 17.2 | 0 | 1 |
| Venomous bites and vitamin C status | 17.2 | 0 | 1 |
| Vitamin C: the dangers of calcium and safety of sodium ascorbate | 17.2 | 0 | 1 |
| How much vitamin C should I take | 17.2 | 0 | 1 |
| Growth Factors and Insulin Stimulate Tyrosine Phosphorylation of the 51C/SHIP2 Protein | 17.2 | 0 | 1 |
| Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters | 17.2 | 0 | 1 |
| Stimulation of human neuronectin secretion by brain-derived growth factors | 17.2 | 0 | 1 |
| Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells | 17.2 | 0 | 1 |
| Assignment of cDNA Encoding Hyaluronic Acid-Binding Protein 1 to Human Chromosome 17p12–p13 | 17.2 | 0 | 1 |
| Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males | 17.2 | 0 | 1 |
| Vitamin C Status of Melbourne Infants | 17.2 | 0 | 1 |
| Fibroblast Growth Factors as Multifunctional Signaling Factors | 17.2 | 0 | 1 |
| MR evaluation of tuberous sclerosis: increased sensitivity with fluid-attenuated inversion recovery and relation to severity of seizures and mental retardation | 17.2 | 0 | 1 |
| Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface | 17.2 | 0 | 1 |
| Receptors for fibroblast growth factors | 17.2 | 0 | 1 |
| Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors | 17.2 | 0 | 1 |
| Fibroblast activation protein: purification, epitope mapping and induction by growth factors | 17.2 | 0 | 1 |
| Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery | 17.2 | 0 | 1 |
| Innovations in natural ingredients and their use in skin care | 17.2 | 0 | 1 |
| The Klotho gene family and the endocrine fibroblast growth factors | 17.2 | 0 | 1 |
| Vitamin C provision improves mood in acutely hospitalized patients | 17.2 | 0 | 1 |
| Vitamin C biosynthesis in prosimians: evidence for the anthropoid affinity of Tarsius | 17.2 | 0 | 1 |
| Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors | 17.2 | 0 | 1 |
| Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later? | 17.2 | 0 | 1 |
| Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice | 17.2 | 0 | 1 |
| Restoration of vitamin C synthesis in transgenic Gulo-/- mice by helper-dependent adenovirus-based expression of gulonolactone oxidase | 17.2 | 0 | 1 |
| Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family | 17.2 | 0 | 1 |
| Ascorbic acid as a sensor of oxidative stress and a regulator of gene expression: the Yin and Yang of vitamin C | 17.2 | 0 | 1 |
| beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors | 17.2 | 0 | 1 |
| Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients | 17.2 | 0 | 1 |
| From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines | 17.2 | 0 | 1 |
| Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles | 17.2 | 0 | 1 |
| Progressive pseudogenization: vitamin C synthesis and its loss in bats | 17.2 | 0 | 1 |
| The controversial place of vitamin C in cancer treatment | 17.2 | 0 | 1 |
| Effect of simultaneous administration of vitamin C, L-cysteine and vitamin E on the melanogenesis | 17.2 | 0 | 1 |
| Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study | 17.2 | 0 | 1 |
| Insulin-like growth factors and their binding proteins: biological actions | 17.2 | 0 | 1 |
| Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors | 17.2 | 0 | 1 |
| A survey of skin problems and skin care regimens in the elderly | 17.2 | 0 | 1 |
| Increased sensitivity to acute and persistent pain in neuron-specific endothelin-1 knockout mice | 17.2 | 0 | 1 |
| Partial molecular characterization of endothelial cell mitogens from human brain: acidic and basic fibroblast growth factors | 17.2 | 0 | 1 |
| Sodium ascorbate (vitamin C) induces apoptosis in melanoma cells via the down-regulation of transferrin receptor dependent iron uptake | 17.2 | 0 | 1 |
| Fibroblast growth factor 5 proto-oncogene is expressed in normal human fibroblasts and induced by serum growth factors | 17.2 | 0 | 1 |
| Articular Cartilage Regeneration With Autologous Peripheral Blood Progenitor Cells and Hyaluronic Acid After Arthroscopic Subchondral Drilling: A Report of 5 Cases With Histology | 17.2 | 0 | 1 |
| Vitamin C and the significance of that "wasted spillover" | 17.2 | 0 | 1 |
| Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities | 17.2 | 0 | 1 |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control | 17.2 | 0 | 1 |
| The protective role of glutathione, cysteine and vitamin C against oxidative DNA damage induced in rat kidney by potassium bromate | 17.2 | 0 | 1 |
| Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment | 17.2 | 0 | 1 |
| Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine | 17.2 | 0 | 1 |
| Vitamin C and post‐suxamethonium pains | 17.2 | 0 | 1 |
| Case update-Progressive skin laxity secondary to penicillamine treatment | 17.2 | 0 | 1 |
| TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD | 17.2 | 0 | 1 |
| Increased sensitivity to lithium-induced neurotoxicity after stroke: a case report | 17.2 | 0 | 1 |
| Hexachlorophene emulsions and antiseptic skin care of newborn infants | 17.2 | 0 | 1 |
| Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid | 17.2 | 0 | 1 |
| Hormonal changes in thalassaemia major | 17.2 | 0 | 1 |
| A case of thymoma with an increased sensitivity to pancuronium | 17.2 | 0 | 1 |
| Increased Sensitivity of the Cholylglycine Breath Test for Detecting Ileal Dysfunction | 17.2 | 0 | 1 |
| Effects of interferons, interferon inducers and growth factors on phagocytosis measured by quantitative determination of synthetic compound ingested by mouse bone marrow-derived macrophages | 17.2 | 0 | 1 |
| Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factors | 17.2 | 0 | 1 |
| Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients | 17.2 | 0 | 1 |